Features  |   May 2013
Drug Shortages: Where Are We and Where Are We Going?
Author Affiliations
  • Heather C. Nixon, M.D.
    Committee on Patient Safety and Education
  • Feyce M. Peralta, M.D.
    Committee on Patient Safety and Education
Article Information
Infectious Disease / Patient Safety / Pharmacology / Advocacy and Legislative Issues / Quality Improvement / Features
Features   |   May 2013
Drug Shortages: Where Are We and Where Are We Going?
ASA Monitor 05 2013, Vol.77, 20-22.
ASA Monitor 05 2013, Vol.77, 20-22.
The blame game is on … from Capitol Hill to the Wall Street Journal to the halls of your local operating room, everyone is buzzing about who is responsible for the epidemic of drug shortages. According to the University of Utah Drug Information Service, the number of active drug shortages by the end of 2012 was 299.1  At the last ASA annual meeting in Washington, D.C., special sessions addressed the New England Compounding Center crisis, and anesthesia providers openly vented their frustrations. Unfortunately, no one party can completely shoulder the blame. The creation, manufacturing, distribution and regulation of pharmaceuticals is a complex process. Any step in this process may result in shortages.2 
First Page Preview
First page PDF preview
First page PDF preview ×
View Large
0 Comments
Submit a Comment
Submit A Comment

Contributors must reveal any conflict of interest. Comments are moderated.

Name
Affiliation & Institution
I have a potential conflict of interest
Comment Title
Comment


This feature is available to Subscribers Only
ASA Member Login or Create an Account ×